Article
Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
BMC gastroenterology - 23 Jul 2021
Fang Tian, Liang Tingting, Wang Yizhuo, Wu Haitao, Liu Shuhan, Xie Linying, Liang Jiaying, Wang Chang, Tan Yehui
Abstract excerpt
BACKGROUND: Approximately 5.0-24.2% of colorectal cancers (CRCs) have inactivating mutations in SMAD4, making it one of the frequently mutated genes in CRC. We thus carried out a comprehensive system review and meta-analysis investigating the prognostic significance and clinicopathological features of SMAD4 gene mutation in CRC patients. METHODS: A detailed literature search was conducted in PubMed, Web of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
